FDA Drug recall D-1663-2012
Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Prin…
- FDA Drug
- Class III
- terminated
- Published 2012-09-05
On 2012-09-05 the FDA classified a Class III recall of Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Prin… by Bracco Diagnostics, citing short Fill: The product is being recalled due to a potential underfill of the affected vials.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1663-2012 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-04-16 |
| Published | 2012-09-05 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Bracco Diagnostics |
| Distribution | US |
Product
Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15
Reason
Short Fill: The product is being recalled due to a potential underfill of the affected vials.
Identifiers
| ndc | 0270-5164-12 |
|---|---|
| ndc | 0270-5164-13 |
| ndc | 0270-5164-14 |
| ndc | 0270-5164-15 |
| code_info | Lot S1P272A Expiry Date: December 2014 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1663-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.